← Back to videosPlay videoWatch on YouTube ↗ 
Ars Live: The rise of GLP-1 drugs: Insights and Unknowns
Ars Technica · Published on October 30, 2024
Loved this video? Share it!
Send it to someone who'll love it, or post it on your networks.
Description
Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.
See also
New Glenn Catastrophe Aftermath: What's Next for the Space Industry? | Ars Live
Ars Technica · Technology
Is the Artificial Intelligence Bubble About to Pop? | Ars Live
Ars Technica · Technology
Tariff Advocacy and Tech: The Semiconductor Scramble | Ars Live
Ars Technica · Technology
The Heat is On: Climate Science in a Rapidly Changing World | Ars Live
Ars Technica · Technology
Red Planet Promises: Is NASA really going to Mars? | Ars Live
Ars Technica · Technology
Ars Live: Bing Chat—Our First Encounter With Manipulative AI
Ars Technica · Technology